Christof Scheid
- Hematology top 1%
- Multiple Myeloma Research and Treatments 49
- Hematopoietic Stem Cell Transplantation 37
- Acute Myeloid Leukemia Research 20
- Chronic Myeloid Leukemia Treatments 14
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 13
- Transplantation top 5%
- Oncology top 5%
- CAR-T cell therapy research 22
- Cancer Treatment and Pharmacology 17
- Immunology top 5%
-
- Protein Degradation and Inhibitors 23
- Co-authors
- Udo HoltickMichael HallekSebastian TheurichMichael von Bergwelt‐BaildonJens ChemnitzAlexander Shimabukuro‐VornhagenNicole SkoetzJens M. Chemnitz
- Cited by
- HematologyGeneticsTransplantation
- Journals
- Journal of Clinical Oncology (10 papers)Blood (24 papers)The Journal of Immunology (1 paper)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Christof Scheid
139 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 110
- Hematology 1.1k
- Genetics 340
- Transplantation 73
- Oncology 648
- Immunology 472
Countries citing papers authored by Christof Scheid
This map shows the geographic impact of Christof Scheid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christof Scheid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christof Scheid more than expected).
Fields of papers citing papers by Christof Scheid
This network shows the impact of papers produced by Christof Scheid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christof Scheid. The network helps show where Christof Scheid may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christof Scheid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 8 | |
| 8 | 2024 | 8 | |
| 9 | 2024 | 0 | |
| 10 | 2023 | 13 | |
| 11 | 2022 | 1 | |
| 12 | 2022 | 6 | |
| 13 | 2021 | 12 | |
| 14 | 2021 | 7 | |
| 15 | COMBINATION THERAPY OF POMALIDOMIDE PLUS RUXOLITINIB IN MYELOFIBROSIS: RESULTS FROM COHORT 1 OF THE MPNSG-0212 TRIAL (NCT01644110) | 2017 | 2 |
| 16 | 2016 | 6 | |
| 17 | 2015 | 2 | |
| 18 | 2013 | 28 | |
| 19 | 2010 | 29 | |
| 20 | 1999 | 42 |
About Christof Scheid
Christof Scheid is a scholar working on Hematology, Genetics and Oncology, having authored 149 papers that have together received 2.2k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (49 papers), Hematopoietic Stem Cell Transplantation (37 papers), Protein Degradation and Inhibitors (23 papers), CAR-T cell therapy research (22 papers), Acute Myeloid Leukemia Research (20 papers), Cancer Treatment and Pharmacology (17 papers), Chronic Myeloid Leukemia Treatments (14 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers). The work is most often cited by research in Hematology (1.1k citations), Genetics (340 citations) and Transplantation (73 citations). Christof Scheid has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Udo Holtick, Michael Hallek, Sebastian Theurich, Michael von Bergwelt‐Baildon, Jens Chemnitz, Alexander Shimabukuro‐Vornhagen, Nicole Skoetz, Jens M. Chemnitz, Peter L. Stern and Volker Diehl. Their work appears in journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.